IPG-8294

N/A

Report date: 2025/03/20 14:57:31
NMEFirst In Class

Base Information

Drug NameIPG-8294
Drug Alias NameIPG-8294IPG8294
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD(Nicotinamide adenine dinucleotide) inhibitors
TargetsNAD(Nicotinamide adenine dinucleotide)
Therapy Area/IndicationsAlzheimer DiseaseMitochondrial Myopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Immunophage Biotech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Immunophage Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseMitochondrial Myopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A